We offer world-leading contract development and manufacturing organization (CDMO) services for biologics, vaccines, and advanced therapies with production facilities in the United States, Europe, and Japan.
Our end-to-end CDMO services are designed to support the development of biopharmaceuticals from preclinical to commercial supply. Our integrated solutions combine scientific expertise, regulatory insights, and advanced manufacturing capabilities to accelerate timelines, ensure compliance, and drive success.
As trusted Partners for Life, we give our customers everything they need to develop and supply treatments and therapies effectively and efficiently to improve patients’ lives.
Comprehensive process development, analytical, and manufacturing services across small-, mid-, and large-scale for a variety of expression systems.
Offering fully integrated CDMO services tailored to the development and manufacturing of lipid nanoparticles (LNPs), liposomes, and mRNA-based therapeutics.
Planning to provide integrated services for ADCs from 2027.
Offering innovative development and manufacturing services from discovery to commercial market supply across a variety of therapeutic cell and viral vector types.